Northfield buys PolyHeme manufacturing facility for $6.7 million

By Elaine Rigoli

Tampa, Fla., June 16 - Northfield Laboratories, Inc. has signed an agreement with First Industrial, LP, to purchase the building Northfield currently leases in Mt. Prospect, Ill., for $6.7 million.

The transaction is scheduled to close in late June.

Northfield said this 106,000-square-foot property will be used as the first planned commercial facility for the manufacture of PolyHeme, the company's human hemoglobin-based oxygen carrier, as well as to house laboratory, quality and administrative personnel.

The facility will be capable of producing about 100,000 units or more of PolyHeme annually, according to a news release.

The company also announced that enrollment is nearing completion in its pivotal phase 3 trauma study.

About 700 patients of the planned total of 720 have been enrolled at Level I trauma centers across the United States.

Located in Evanston, Ill., Northfield Laboratories develops oxygen-carrying resuscitative fluid for the treatment of urgent, large volume blood loss in trauma and resultant surgical settings.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.